Point72 Asset Management’s Arcturus Therapeutics ARCT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80.1K | Sell |
6,154
-4,163
| -40% | -$54.2K | ﹤0.01% | 1246 |
|
|
2025
Q1 | $109K | Buy |
+10,317
| New | +$109K | ﹤0.01% | 1162 |
|
|
2024
Q3 | – | Sell |
-244,154
| Closed | -$5.95M | – | 1220 |
|
|
2024
Q2 | $5.95M | Sell |
244,154
-91,224
| -27% | -$2.22M | 0.02% | 605 |
|
|
2024
Q1 | $11.3M | Buy |
335,378
+317,800
| +1,808% | +$10.7M | 0.03% | 561 |
|
|
2023
Q4 | $554K | Sell |
17,578
-317,700
| -95% | -$10M | ﹤0.01% | 991 |
|
|
2023
Q3 | $8.57M | Buy |
335,278
+330,875
| +7,515% | +$8.45M | 0.03% | 605 |
|
|
2023
Q2 | $126K | Sell |
4,403
-75,985
| -95% | -$2.18M | ﹤0.01% | 1000 |
|
|
2023
Q1 | $1.93M | Buy |
80,388
+15,888
| +25% | +$381K | 0.01% | 806 |
|
|
2022
Q4 | $1.09M | Sell |
64,500
-552,624
| -90% | -$9.37M | ﹤0.01% | 810 |
|
|
2022
Q3 | $9.15M | Sell |
617,124
-296,199
| -32% | -$4.39M | 0.04% | 492 |
|
|
2022
Q2 | $14.4M | Buy |
913,323
+488,123
| +115% | +$7.68M | 0.06% | 372 |
|
|
2022
Q1 | $11.5M | Buy |
+425,200
| New | +$11.5M | 0.05% | 433 |
|
|
2020
Q3 | – | Sell |
-223,013
| Closed | -$10.4M | – | 852 |
|
|
2020
Q2 | $10.4M | Buy |
+223,013
| New | +$10.4M | 0.07% | 314 |
|